Phase 2 Study of INBRX-109 in Conventional Chondrosarcoma
Condition:   Conventional Chondrosarcoma Interventions:   Drug: INBRX-109;   Drug: Placebo Sponsor:   Inhibrx, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2021 Category: Research Source Type: clinical trials

Neutrophils in Bone Sarcomas
Condition:   Osteosarcoma, Chondrosarcoma Intervention:   Other: No intervention Sponsor:   Université de Reims Champagne-Ardenne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2021 Category: Research Source Type: clinical trials